Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Pharma Industry News XtalPi raises $319m for AI based drug research and development XtalPi, a pharma company that leverages artificial intelligence (AI) for drug discovery and development, has raised $318.8 million… bypharmanewsdailySeptember 28, 2020